Lecia V. Sequist Provides an Overview of T790M Mutations in NSCLC

Article

Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.

Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene. T790M is the primary cause of treatment resistance in EGFR-positive patients with non-small cell lung cancer (NSCLC).

Related Videos
Dr. Manisha Thakuria in an interview with CURE
Dr. Beth Goldstein in an interview with CURE
D'Agostino in an interview with CURE
Dr. Chapman-Davis in an interview with CURE
Dr. Psutka in an interview with CURE
Dr. Nitin Ohri in an interview with CURE
Dr. Ngwa in an interview with CURE
Dr. Claudia DeYoung in an interview with CURE
Dr. Toni Choueiri in an interview with CURE at the 2023 KCRS
Related Content